The global medical industry experienced a 21% decline in the number of artificial intelligence-related patent applications in Q1 2023 compared with the previous quarter. The total number of artificial intelligence-related grants dropped by 39% in Q1 2023, according to GlobalData’s Patent Analytics. GlobalData’s Medical Device Predictions 2023 – Thematic Intelligence report provides a detailed understanding of how artificial intelligence and the other key themes such as Cybersecurity, Robotics, and Wearable Tech impact the medical device industry. Buy the report here.
Notably, the number of artificial intelligence-related patent applications in the medical industry was 1,443 in Q1 2023, versus 1,838 in the prior quarter.
The top five companies accounted for 12% of patenting activity
Analysis of patenting activity by companies shows that Siemens filed the most artificial intelligence patents within the medical industry in Q1 2023. The company filed 58 artificial intelligence-related patents in the quarter, compared with 33 in the previous quarter. It was followed by Koninklijke Philips with 57 artificial intelligence patent filings, Fujifilm (22 filings), and F. Hoffmann-La Roche (22 filings) in Q1 2023.
Patenting activity was driven by China with a 17% share of total patent filings
The largest share of artificial intelligence related patent filings in the medical industry in Q1 2023 was in China with 17%, followed by Japan (10%) and South Korea (8%). The share represented by China was 7% lower than the 24% share it accounted for in Q4 2022.
To further understand GlobalData's analysis on Medical Device Predictions 2023 - Thematic Intelligence buy the report here.